Filing Details

Accession Number:
0001209191-17-054194
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-27 21:38:49
Reporting Period:
2017-09-25
Accepted Time:
2017-09-27 21:38:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1510580 Kite Pharma Inc. KITE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1222082 M Cynthia Butitta C/O Kite Pharma, Inc.
2225 Colorado Avenue
Santa Monica CA 90404
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-09-25 8,000 $0.00 125,795 No 4 A Direct
Common Stock Disposition 2017-09-25 4,228 $179.66 121,567 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. The shares were sold to cover the tax obligation that occurred upon the vesting of an RSU.